Miho Nakajima

3.5k total citations
9 papers, 408 citations indexed

About

Miho Nakajima is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Miho Nakajima has authored 9 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pathology and Forensic Medicine and 2 papers in Cancer Research. Recurrent topics in Miho Nakajima's work include Cancer Genomics and Diagnostics (2 papers), Nausea and vomiting management (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Miho Nakajima is often cited by papers focused on Cancer Genomics and Diagnostics (2 papers), Nausea and vomiting management (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). Miho Nakajima collaborates with scholars based in Japan and United States. Miho Nakajima's co-authors include Nathaniel Heintz, Eric F. Schmidt, Joseph D. Dougherty, Takeshi Izawa, Randy Foster, Ko Shimamoto, Nam‐Hai Chua, Jerry Silver, Koichiro Ishida and Yoshiaki Hirosue and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Plant Cell.

In The Last Decade

Miho Nakajima

9 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Miho Nakajima Japan	6	219	90	85	83	52	9	408
Klaus Wanisch United Kingdom	9	259 1.2×	20 0.2×	145 1.7×	99 1.2×	195 3.8×	10	518
С. В. Саложин Russia	10	507 2.3×	52 0.6×	159 1.9×	45 0.5×	124 2.4×	20	668
Virve Kärkkäinen Finland	11	239 1.1×	16 0.2×	159 1.9×	85 1.0×	80 1.5×	24	482
Pascale Bouchard-Cannon Canada	8	138 0.6×	47 0.5×	37 0.4×	43 0.5×	81 1.6×	9	442
Katherine E. Savell United States	9	364 1.7×	16 0.2×	118 1.4×	43 0.5×	113 2.2×	10	477
Arthur J. Kuipers Netherlands	8	247 1.1×	69 0.8×	96 1.1×	41 0.5×	63 1.2×	8	502
Viviana F Bumaschny Argentina	10	207 0.9×	87 1.0×	98 1.2×	46 0.6×	146 2.8×	12	570
Jennifer Bonner United States	9	421 1.9×	32 0.4×	76 0.9×	29 0.3×	189 3.6×	20	639
Nobuhiro Kurabayashi Japan	12	187 0.9×	120 1.3×	68 0.8×	54 0.7×	105 2.0×	19	562
Lars R. Jensen Germany	12	253 1.2×	30 0.3×	102 1.2×	42 0.5×	40 0.8×	32	395

Countries citing papers authored by Miho Nakajima

Since Specialization

Citations

This map shows the geographic impact of Miho Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miho Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miho Nakajima more than expected).

Fields of papers citing papers by Miho Nakajima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miho Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miho Nakajima. The network helps show where Miho Nakajima may publish in the future.

Co-authorship network of co-authors of Miho Nakajima

This figure shows the co-authorship network connecting the top 25 collaborators of Miho Nakajima. A scholar is included among the top collaborators of Miho Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miho Nakajima. Miho Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Sugiyama, Masanaka, Miho Nakajima, Yuko Watanabe, et al.. (2023). Safety and efficacy of multiple tyrosine kinase inhibitors in pediatric/adolescent and young adult patients with relapsed or refractory osteosarcomas: A single‐institution retrospective analysis. Pediatric Blood & Cancer. 70(7). e30360–e30360. 4 indexed citations

Ishimaru, S, Tatsunori Shimoi, Kuniko Sunami, et al.. (2023). Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trial. International Journal of Clinical Oncology. 29(2). 89–95. 4 indexed citations

Yamashita, Satoshi, Miho Nakajima, Tadashi Kumamoto, et al.. (2022). A quantification method of somatic mutations in normal tissues and their accumulation in pediatric patients with chemotherapy. Proceedings of the National Academy of Sciences. 119(31). e2123241119–e2123241119. 8 indexed citations

Nakajima, Miho, Hong-Fen Guo, Sayed Shahabuddin Hoseini, et al.. (2021). Potent antitumor effect of T cells armed with anti‐GD2 bispecific antibody. Pediatric Blood & Cancer. 68(7). e28971–e28971. 8 indexed citations

Saito, Yoshimasa, Tadashi Kumamoto, S Ishimaru, et al.. (2019). Evaluation of aprepitant and fosaprepitant in pediatric patients. Pediatrics International. 61(3). 235–239. 10 indexed citations

Dougherty, Joseph D., Eric F. Schmidt, Miho Nakajima, & Nathaniel Heintz. (2010). Analytical approaches to RNA profiling data for the identification of genes enriched in specific cells. Nucleic Acids Research. 38(13). 4218–4230. 231 indexed citations

Gohji, Kazuo, Yoji Katsuoka, Michael Okamoto, et al.. (2000). [Human heparanase: roles in invasion and metastasis of cancer].. PubMed. 46(10). 757–62. 5 indexed citations

Inui, Akio, Misako Okita, Miho Nakajima, et al.. (1998). Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y.. PubMed. 110(3). 171–82. 37 indexed citations

Izawa, Takeshi, Randy Foster, Miho Nakajima, Ko Shimamoto, & Nam‐Hai Chua. (1994). The rice bZIP transcriptional activator RITA-1 is highly expressed during seed development.. The Plant Cell. 6(9). 1277–1287. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact